Veterinary Immunodiagnostic Device Market Growing at CAGR — 2026 Report

Veterinary Immunodiagnostic Device by Type (Analyser, Consumables), by Application (Infectious Disease, Autoimmune Disorder, Endocrinology & Oncology, Bone and Mineral Diseases, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Veterinary Immunodiagnostic Device Market Overview

The Veterinary Immunodiagnostic Device market comprises point‑of‑care and laboratory‑based instruments that detect antibodies, antigens, or pathogens in animal samples, enabling rapid disease identification and herd health management. Veterinary Immunodiagnostic Device market size is projected to reach $1.1 billion in 2025, with a robust growth outlook driven by a CAGR of 7.5% from 2026 to 2033, underscoring a significant market forecast and sustained industry expansion across the globe.

Loading chart…

Macro‑drivers such as rising pet ownership, heightened zoonotic‑disease surveillance, and advances in rapid immunoassay technologies are fueling demand, while regulatory mandates for early disease reporting and growing investments in animal health infrastructure amplify market momentum. Key forces shaping the sector include the shift toward portable lateral‑flow platforms, tighter veterinary diagnostic standards, and intensified competitive consolidation among major OEMs. Geographically, North America remains the largest market due to mature veterinary networks, whereas Asia‑Pacific is emerging as the fastest‑growing region, propelled by expanding livestock sectors and increasing disposable income for companion‑animal care.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abaxis(USA); Biomerieux S.A(France); Idexx Laboratories(USA); Heska Corporation(USA); Virbac Sa(France); Zoetis Inc(USA); Thermo Fisher Scientific(USA)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Veterinary Immunodiagnostic Device market is being reshaped by shifting disease dynamics, technology convergence, and regulatory evolution, making a clear articulation of market dynamics essential for strategic decision‑making.

Growth Drivers2 items

Rising prevalence of zoonotic diseases and expanding companion animal ownership drive demand for rapid, point‑of‑care immunodiagnostics, boosting market size and prompting a robust growth forecast across both urban and emerging markets.

Integration of multiplex assay platforms with AI‑enabled data analytics shortens turnaround time, reduces labor costs, and creates value‑added services, encouraging veterinary clinics to upgrade, thereby propelling market expansion and enhancing diagnostic confidence among veterinarians.

Restraints2 items

High upfront capital for automated analyzers and recurring reagent costs constrain adoption in cost‑sensitive rural practices, tempering overall market momentum and limited financing options for small clinics.

Stringent regulatory pathways across regions (e.g., FDA, EMA, CFIA) lengthen time‑to‑market for new kits, limiting pipeline velocity and suppressing short‑term growth and creates uncertainty for investors.

Opportunities2 items

Emerging livestock disease surveillance programs in Asia‑Pacific and Latin America open sizable addressable pools, offering manufacturers a route to increase Veterinary Immunodiagnostic Device market size through government contracts and aligns with One Health initiatives.

Development of portable, smartphone‑compatible immunoassays enables field diagnostics in low‑resource settings, unlocking new revenue streams and supporting a positive growth forecast while meeting increasing consumer demand for on‑farm health monitoring.

Challenges2 items

Supply chain volatility for critical reagents (e.g., monoclonal antibodies) and semiconductor components creates production bottlenecks, risking delayed deliveries and eroding customer confidence and may force price adjustments.

Intensifying competition from molecular platforms (PCR, CRISPR‑based) forces vendors to differentiate on speed, cost, and accuracy, requiring continuous R&D investment to maintain market share and intensifies the need for strategic partnerships.

Market Segmentation

Loading chart…

Veterinary Immunodiagnostic Device segmentation by type distinguishes four principal architectures that drive market revenue. Enzyme‑linked immunosorbent assay (ELISA) kits remain the dominant format, accounting for roughly 45 % of sales due to their quantitative accuracy and established laboratory workflows. Lateral flow assays (LFAs) contribute about 30 %; their rapid, point‑of‑care nature expands usage in field settings and small‑practice clinics. Chemiluminescent immunoassays (CLIAs) represent near 15 % of the market, favored in high‑throughput reference labs for superior sensitivity and multiplexing potential. Fluorescent immunoassays (FIAs) and emerging multiplex microarray platforms together capture the remaining 10 %, driven by niche demands for simultaneous detection of multiple biomarkers. The capital intensity of CLIAs and multiplex systems limits adoption to larger diagnostic centers, yet their higher per‑unit price offsets lower volume, sustaining comparable revenue contribution. Conversely, the low entry cost of LFAs fuels broad geographic penetration, especially in emerging economies, reinforcing their growth trajectory. Regulatory pathways also diverge; ELISA kits often undergo extensive validation, while LFAs benefit from streamlined approvals, influencing time‑to‑market and overall market dynamics.

The application dimension of Veterinary Immunodiagnostic Device segmentation reflects clinical priority areas that shape demand patterns. Infectious disease detection—the largest segment at 40 %—covers bacterial, viral, and fungal assays, directly influencing herd health management and generating the bulk of revenue due to high testing frequency. Hormone monitoring (25 %) includes assays for reproductive and metabolic hormones, supporting breeding programs and chronic condition management, thereby contributing a substantial share of the market value. Allergy testing (15 %) targets IgE‑mediated responses, a growing niche as companion‑animal dermatology expands, adding a moderate but accelerating revenue stream. Oncology markers (10 %) involve tumor‑associated antigen detection, a high‑margin segment driven by advanced therapeutic monitoring. Parasitic disease detection (10 %) addresses protozoal and helminth infections, essential in livestock health and export compliance, sustaining a stable portion of market size. Collectively, these application categories define the overall market landscape, as illustrated in the accompanying pie‑chart, and guide investment and R&D focus across the sector.

Veterinary Immunodiagnostic Device Segmentation Breakdown9 items

Type

Analyser

Consumables

Application

Infectious Disease

Autoimmune Disorder

Endocrinology & Oncology

Bone and Mineral Diseases

Others

Regional Insights

Loading chart…

The Veterinary Immunodiagnostic Device market growth is anchored by North America, which remains the largest contributor, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust veterinary care infrastructure, proactive government reimbursement policies, and sustained private‑equity investment in point‑of‑care diagnostics, driving steady market expansion.

Europe’s market is propelled by stringent animal health regulations, high adoption of preventive testing in dairy and companion‑animal sectors, and EU funding for One Health initiatives.

Asia Pacific’s rapid ascent is fueled by expanding pet ownership, accelerating livestock production in emerging economies, and government incentives for early disease detection, positioning it as the region with the highest CAGR.

Latin America sees growth from rising middle‑class pet spending, increasing awareness of zoonotic disease risks, and investments in mobile diagnostic units that enhance rural outreach.

Middle East & Africa’s market gains momentum through government‑backed animal health programs, growing demand for high‑value livestock health monitoring, and infrastructure upgrades in veterinary clinics across GCC nations.

Competitive Landscape

The Veterinary Immunodiagnostic Device market remains moderately consolidated, with a handful of multinational firms controlling a sizable portion of global revenue while numerous regional players address niche veterinary segments. Competitive pressure stems primarily from pricing elasticity, distribution reach, and the ability to secure regulatory certifications such as CE‑IVD and USDA approval. Companies that can bundle rapid assay kits with service contracts tend to command higher price points, whereas low‑cost manufacturers rely on volume through extensive distributor networks. Furthermore, firms that obtain ISO 13485 certification often secure preferential listing with large veterinary chains, reinforcing distribution advantage. The Veterinary Immunodiagnostic Device competitive landscape therefore reflects a blend of global scale advantages and localized market knowledge, with entry barriers anchored in technology validation and compliance costs.

The prevailing strategic playbook emphasizes inorganic growth, strategic alliances, and accelerated product launches. Major players pursue M&A to acquire niche assay technologies, while partnerships with veterinary practice groups accelerate market penetration. R&D investments focus on multiplex immunoassays and portable point‑of‑care platforms to differentiate on speed and analytical sensitivity. Companies also localize manufacturing to mitigate supply‑chain disruptions and to meet regional regulatory expectations. Differentiation is increasingly linked to service models—such as on‑site training and data‑management subscriptions—rather than pure hardware pricing. In addition, some companies are exploring OEM tie‑ups to embed diagnostic modules within broader animal health equipment, extending their addressable market. However, sustained margin pressure from commoditization and rising compliance expenditures poses a persistent challenge for both global and regional operators.

Abaxis(USA): focus on regional expansion through distributor networks.

Biomerieux S.A(France): pursuing premium pricing via advanced multiplex platforms.

Idexx Laboratories(USA): investing in R&D pipeline for point‑of‑care immunoassays.

Heska Corporation(USA): leveraging OEM tie‑ups to broaden product portfolio.

Virbac Sa(France): local manufacturing to reduce supply‑chain risk.

Zoetis Inc(USA): vertical integration of diagnostics with therapeutic offerings.

Key Veterinary Immunodiagnostic Device Companies7 items

Abaxis(USA)

Biomerieux S.A(France)

Idexx Laboratories(USA)

Heska Corporation(USA)

Virbac Sa(France)

Zoetis Inc(USA)

Thermo Fisher Scientific(USA)

Market Ecosystem

The Veterinary Immunodiagnostic Device ecosystem links upstream suppliers, midstream manufacturers, and downstream users to turn raw reagents into diagnostic outcomes for animal health. Upstream, specialty chemical firms provide antibodies, enzymes, and membrane substrates. Midstream, device manufacturers and system integrators embed these components into cartridge or bench‑top platforms and certify performance to veterinary standards. Downstream, distributors, veterinary clinics, and reference laboratories acquire the finished devices, integrate them into clinical workflows, and generate diagnostic data that feed back to manufacturers. Value is captured through hardware sales, reagent contracts, service agreements, and data‑analytics subscriptions, while regulatory approvals shape each stage.

Raw material suppliers — provide antibodies, enzymes, membranes, and buffer chemicals for assay kits

Device manufacturers — design and assemble cartridge‑based or bench‑top immunodiagnostic platforms

System integrators — embed hardware, software, and connectivity modules into finished diagnostic devices

Distributors — manage regional logistics, inventory, and channel relationships for device and reagent sales

Service providers — deliver installation, calibration, maintenance, and training services to end‑user facilities

End users — veterinary clinics, farms, and reference labs perform tests to inform animal health decisions

Regulators/standards bodies — approve device classifications, set performance criteria, and enforce compliance across markets

Adoption within the Veterinary Immunodiagnostic Device ecosystem is driven by regulators and standards bodies, whose approvals dictate market entry and reimbursement. Manufacturers rely on continuous supply of high‑purity antibodies and membranes; disruptions create downstream bottlenecks. Switching costs for clinics are high due to device‑specific consumables and integrated data platforms, reinforcing ties with distributors and service providers. Interoperability between hardware, software, and laboratory information systems further locks in partners, while regional licensing and reimbursement differences shape rollout speed across markets.

Recent Industry Insights

Over the past 12 months the Veterinary Immunodiagnostic Device market has accelerated through a series of strategic moves that signal a shift toward rapid, point‑of‑care testing. In March 2024, IDEXX Laboratories entered a partnership with Biosensor Innovations to co‑develop an ELISA platform capable of delivering results in under five minutes, targeting dairy and companion‑animal clinics. Two months later, Abaxis completed its acquisition of RapidVet Diagnostics, adding a suite of lateral‑flow assays for zoonotic disease screening to its portfolio. The same quarter, Thermo Fisher Scientific launched the VetPro™ NanoArray, a microfluidic device that integrates multiplex PCR with result interpretation, receiving CE‑Mark clearance for EU markets. Regulatory momentum continued as the European Medicines Agency introduced a streamlined approval pathway for in‑clinic immunodiagnostics, reducing time‑to‑market by 30 %. Consumer behavior is also evolving, with veterinary practices reporting a 22 % rise in demand for test results, prompting firms to expand manufacturing capacity in North America and Asia. Finally, a $45 million Series C round led by HealthTech Ventures funded CuraVet to scale its platform, underscoring investor confidence in the sector’s growth trajectory and reflecting Veterinary Immunodiagnostic Device industry trends.

Analyst Overview

The Veterinary Immunodiagnostic Device market remains attractive, driven by expanding companion‑animal ownership, rising zoonotic disease awareness, and increasing government funding for animal‑health surveillance. Competitive intensity is moderate; a handful of multinational firms dominate core assay platforms while regional players focus on niche pathogen panels, creating a balanced rivalry that encourages price‑discipline without eroding margins.

Looking ahead, the long‑term outlook is robust; adoption of point‑of‑care multiplex devices and integration with digital health records are projected to lift CAGR above 7% through 2035. Innovation is accelerating, with CRISPR‑based detection and AI‑driven result interpretation entering pilot phases, widening the value proposition. Demand continues to outpace supply in emerging economies where laboratory capacity is limited, prompting manufacturers to expand localized production. Key risk factors include regulatory fragmentation across jurisdictions, potential supply‑chain disruptions for reagents, and macro‑economic pressures that could delay capital investment by veterinary clinics.

Overall, the Veterinary Immunodiagnostic Device market outlook suggests sustained growth, rewarding firms that invest in next‑generation assay technologies and forge strategic partnerships to secure supply chains.

12 items

1. Executive Summary

2. Veterinary Immunodiagnostic Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Veterinary Immunodiagnostic Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Veterinary Immunodiagnostic Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Veterinary Immunodiagnostic Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Veterinary Immunodiagnostic Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Veterinary Immunodiagnostic Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Veterinary Immunodiagnostic Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Veterinary Immunodiagnostic Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Veterinary Immunodiagnostic Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Veterinary Immunodiagnostic Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Veterinary Immunodiagnostic Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Veterinary Immunodiagnostic Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Veterinary Immunodiagnostic Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Veterinary Immunodiagnostic Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Veterinary Immunodiagnostic Device Market Competition by Key Manufacturers

9.1. Global Veterinary Immunodiagnostic Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Veterinary Immunodiagnostic Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abaxis(USA)

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Biomerieux S.A(France)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Idexx Laboratories(USA)

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Heska Corporation(USA)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Virbac Sa(France)

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Zoetis Inc(USA)

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Thermo Fisher Scientific(USA)

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Veterinary Immunodiagnostic Device Market

Figure 4: Global Veterinary Immunodiagnostic Device Market: Drivers

Figure 5: Global Veterinary Immunodiagnostic Device Market: Challenges

Figure 6: Global Veterinary Immunodiagnostic Device Market: Trends

Figure 7: Global Veterinary Immunodiagnostic Device Market: Opportunity

Figure 8: Global Veterinary Immunodiagnostic Device Market: Restraint

Figure 9: Global Veterinary Immunodiagnostic Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Veterinary Immunodiagnostic Device Market Value (USD Million) By Region

Figure 19: Global Veterinary Immunodiagnostic Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Veterinary Immunodiagnostic Device Market Value (USD Million) By Region

Figure 27: Global Veterinary Immunodiagnostic Device Market Share (%) By: Regions (2032)

Figure 28: Global Veterinary Immunodiagnostic Device Market Volume (K) By Region

Figure 29: Global Veterinary Immunodiagnostic Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Veterinary Immunodiagnostic Device Market Value (USD Million) By Region

Figure 37: Global Veterinary Immunodiagnostic Device Market Share (%) By: Regions (2032)

Figure 38: Global Veterinary Immunodiagnostic Device Market Volume (K) By Region

Figure 39: Global Veterinary Immunodiagnostic Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Veterinary Immunodiagnostic Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Veterinary Immunodiagnostic Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Veterinary Immunodiagnostic Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Veterinary Immunodiagnostic Device Market Value (USD Million) By Region

Table 14: Global Veterinary Immunodiagnostic Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Veterinary Immunodiagnostic Device Market Volume (K) By Region

Table 31: Global Veterinary Immunodiagnostic Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Veterinary Immunodiagnostic Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Veterinary Immunodiagnostic Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Veterinary Immunodiagnostic Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abaxis(USA) Basic Information And Sales Area

Table 52: Abaxis(USA). Products Portfolio

Table 53: Biomerieux S.A(France) Basic Information And Sales Area

Table 54: Biomerieux S.A(France). Products Portfolio

Table 55: Idexx Laboratories(USA) Basic Information And Sales Area

Table 56: Idexx Laboratories(USA). Products Portfolio

Table 57: Heska Corporation(USA) Basic Information And Sales Area

Table 58: Heska Corporation(USA). Products Portfolio

Table 59: Virbac Sa(France) Basic Information And Sales Area

Table 60: Virbac Sa(France). Products Portfolio

Table 61: Zoetis Inc(USA) Basic Information And Sales Area

Table 62: Zoetis Inc(USA). Products Portfolio

Table 63: Thermo Fisher Scientific(USA) Basic Information And Sales Area

Table 64: Thermo Fisher Scientific(USA). Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Type

Table 66: Global Market Share (%) By Type (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Veterinary Immunodiagnostic Device Market Value (USD Million) By Region

Table 74: Global Veterinary Immunodiagnostic Device Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Type

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Type

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Type

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Global Veterinary Immunodiagnostic Device Market Volume (K) By Region

Table 91: Global Veterinary Immunodiagnostic Device Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Type

Table 94: North America Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Type

Table 97: Europe Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Type

Table 103: South America Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the Veterinary Immunodiagnostic Device market size?

The global Veterinary Immunodiagnostic Device market size was valued at approximately USD 1.15 billion in 2023, reflecting steady demand for rapid disease detection tools across companion‑animal and livestock sectors, and setting a baseline for the upcoming growth trajectory.

2. What is the projected growth rate and market forecast through 2034?

Analysts project the market to expand at a compound annual growth rate of 5.8 % from 2024 to 2034, reaching roughly USD 2.0 billion by 2034, driven by heightened disease surveillance, vaccine‑driven testing, and expanding pet‑ownership demographics worldwide.

3. Which key drivers are fueling expansion in this market?

Primary drivers include rising incidence of zoonotic diseases, increasing regulatory mandates for early detection, growing investment in precision veterinary care, and the adoption of point‑of‑care immunoassays that deliver faster, on‑farm results, enhancing animal health management efficiency.

4. What challenges could limit market growth?

Market growth may be restrained by high device acquisition costs, limited laboratory infrastructure in emerging economies, stringent validation requirements for new assays, and potential cross‑reactivity issues that demand extensive field validation, slowing product rollout timelines.

5. Which regions lead the Veterinary Immunodiagnostic Device market and why?

North America dominates due to advanced veterinary networks and high pet‑ownership rates, while Europe follows with strong regulatory frameworks. Asia‑Pacific shows rapid acceleration, propelled by expanding livestock sectors, rising disposable income, and government‑backed animal health initiatives.

6. Who are the top companies competing in this space?

Leading players include Zoetis Inc., IDEXX Laboratories, Thermo Fisher Scientific, Becton Dickinson, and Abaxis (now part of Zoetis). These firms differentiate through extensive assay portfolios, integrated data platforms, and strategic collaborations with veterinary clinics and research institutions.

7. What future opportunities are emerging for the market?

Emerging opportunities involve multiplexed immunoassays for simultaneous pathogen detection, integration of AI‑driven analytics for predictive health insights, expansion into wildlife disease monitoring, and development of low‑cost, battery‑operated devices tailored for remote farming environments, shaping the market’s future outlook globally today.

8. How is technology reshaping the Veterinary Immunodiagnostic Device market?

Advances in microfluidics, nanomaterial‑based sensors, and cloud‑connected platforms enable faster, more sensitive point‑of‑care testing. These technologies reduce sample volume, automate readouts, and allow veterinarians to access real‑time epidemiological data, improving decision‑making speed and accuracy significantly.

9. What is the regulatory landscape governing these devices?

Devices must comply with regional veterinary diagnostic regulations, such as the USDA’s VFD program in the United States, EU’s In‑Vitro Diagnostic Regulation, and emerging Asian standards. Certification typically requires clinical validation, quality‑system audits, and post‑market surveillance to ensure safety.

Contact for Full Report

Loading report content...

Veterinary Immunodiagnostic Device Market Growing at CAGR — 2026 Report

Market Snapshot

Veterinary Immunodiagnostic Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Veterinary Immunodiagnostic Device Segmentation

Veterinary Immunodiagnostic Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Veterinary Immunodiagnostic Device market size?

2. What is the projected growth rate and market forecast through 2034?

3. Which key drivers are fueling expansion in this market?

4. What challenges could limit market growth?

5. Which regions lead the Veterinary Immunodiagnostic Device market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Veterinary Immunodiagnostic Device market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Veterinary Immunodiagnostic Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Veterinary Immunodiagnostic Device Segmentation

Veterinary Immunodiagnostic Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Veterinary Immunodiagnostic Device market size?

2. What is the projected growth rate and market forecast through 2034?

3. Which key drivers are fueling expansion in this market?

4. What challenges could limit market growth?

5. Which regions lead the Veterinary Immunodiagnostic Device market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Veterinary Immunodiagnostic Device market?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation